News
Eisai to Take over Manufacturing and Marketing Approval for...
Eisai Co., Ltd. announced that it will take over by transfer the manufacturing and marketing approval of Parkinson's disease treatment Equfina 50mg TABLETS (safinamide mesilate,...
News
China shows off Covid-19 vaccines for first time
China has put its homegrown coronavirus vaccines on display for the first time, as the country where the contagion was discovered looks to shape the...
Clinical Trials
Sinovac Biotech’s COVID-19 vaccine enters phase 3 trial globally
A COVID-19 vaccine candidate developed by Beijing-based Sinovac Life Sciences Corp has obtained preliminary approval in Bangladesh for entering phase III clinical trials, the company.
"Our...
News
ADMA Biologics Highlights Launch of COVID-19 ImmunoRank Neutralization MICRO-ELISA...
ADMA Biologics, Inc., an end-to-end commercial biopharmaceutical company dedicated to manufacturing, marketing and developing specialty plasma-derived biologics, today announced the launch of COVID-19 ImmunoRank Neutralization...
News
UNICEF to lead procurement and supply of COVID-19 vaccines...
UNICEF is leading efforts to procure and supply COVID-19 vaccines in what could possibly be the world’s largest and fastest ever procurement and supply of...
News
Mesoblast Limited receives ethics approval to treat COVID-19 patients...
Mesoblast Limited, global leader in allogeneic cellular medicines for inflammatory diseases, announced that it has received ethics approval to include Australian hospitals in thePhase 3...
News
Delivery of COVID-19 vaccine: DHL study shows how public...
With first emergency use authorizations for COVID-19 vaccines expected to be effective in the last quarter of 2020, logistics providers are challenged to rapidly establish...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.